Top

Cognitive Therapy and Research

Gepubliceerd in:

15-09-2020 | Original Article

Residual Anxiety in Patients with Bipolar Disorder in Full or Partial Remission: Metacognitive Beliefs and Neurocognitive Function

Auteurs: M. L. Reinholdt-Dunne, I. Seeberg, A. Blicher, N. Normann, M. Vinberg, L. V. Kessing, K. W. Miskowiak

Gepubliceerd in: Cognitive Therapy and Research | Uitgave 1/2021

Abstract

Background

Maladaptive metacognitive beliefs are frequent during depressive states of bipolar disorder (BD). Still, it is unclear whether they persist in remitted phases and play a role in patients’ residual anxiety. The study aimed to investigate whether remitted patients with BD display maladaptive metacognitive beliefs, and whether these beliefs are associated with more residual anxiety and lower attention control.

Methods

Patients with BD in full remission (n = 28) and healthy control participants (HCs) (n = 31) were assessed with self-reported questionnaires measuring metacognitions, anxiety, attention, and a screening for cognitive impairment as well as two computerised attention tasks.

Results

Patients with BD exhibited higher levels of maladaptive metacognitive beliefs than HCs, also after adjustment for subsyndromal mood symptoms. Patients with BD also showed reduced attention control and cognitive impairments. Across the entire sample, more maladaptive metacognitive beliefs were associated with more anxiety symptoms, poorer cognition and lower attention control.

Conclusions

Maladaptive metacognitive beliefs are associated with residual anxiety in remitted patients with BD. Treatments that specifically target maladaptive metacognitive beliefs may have potential to reduce anxiety in remitted phases of BD and enhance patients’ functional recovery and quality of life.

vorige artikel Developmental Differences in Child and Adolescent Reasoning About Anxiety Sensations

volgende artikel Advancing the Assessment of Mindfulness-Based Meditation Practice: Psychometric Evaluation of the Mindfulness Adherence Questionnaire

Albert, U., Rosso, G., Maina, G., & Bogetto, F. (2008). Impact of anxiety disorder comorbidity on quality of life in euthymic bipolar disorder patients: Differences between bipolar I and II subtypes. Journal of Affective Disorders, 105(1–3), 297–303. https://doi.org/10.1016/j.jad.2007.05.020.CrossRefPubMed

Altamura, A., Dell’Osso, B., Berlin, H., Buoli, M., Bassetti, R., & Mundo, E. (2010). Duration of untreated illness and suicide in bipolar disorder: A naturalistic study. European Archives of Psychiatry and Clinical Neuroscience, 260(5), 385–391. https://doi.org/10.1007/s00406-009-0085-2.CrossRefPubMed

Amerio, A. (2019). Suicide risk in comorbid bipolar disorder and obsessive-compulsive disorder: A systematic review (Review Article). Indian Journal of Psychology Medicine, 41(2), 133. https://doi.org/10.4103/IJPSYM.IJPSYM_367_18.CrossRef

Armstrong, T., & Olatunji, B. O. (2012). Eye tracking of attention in the affective disorders: A meta-analytic review and synthesis. Clinical Psychology Review, 32(8), 704–723. https://doi.org/10.1016/j.cpr.2012.09.004.CrossRefPubMedPubMedCentral

Batmaz, S., Ulusoy Kaymak, S., Kocbiyik, S., & Turkcapar, M. H. (2014). Metacognitions and emotional schemas: A new cognitive perspective for the distinction between unipolar and bipolar depression. Comprehensive Psychiatry, 55(7), 1546–1555. https://doi.org/10.1016/j.comppsych.2014.05.016.CrossRefPubMed

Beck, A. T., & Steer, R. A. (1993). Beck Anxiety Inventory: manual. Cambridge: The Psychological Corporation, Harcourt Brace & Company.

Boylan, K. R., Bieling, P. J., Marriott, M., Begin, H., Young, L. T., & MacQueen, G. M. (2004). Impact of comorbid anxiety disorders on outcome in a cohort of patients with bipolar disorder. Journal of Clinical Psychiatry, 65(8), 1106–1113.CrossRefPubMed

Capobianco, L., Reeves, D., Morrison, A. P., & Wells, A. (2018). Group metacognitive therapy vs. mindfulness meditation therapy in a transdiagnostic patient sample: A randomised feasibility trial. Psychiatry Research, 259, 554–561. https://doi.org/10.1016/j.psychres.2017.11.045.CrossRefPubMed

Craske, M. G. (2012). Transdiagnostic treatment for anxiety and depression. Depress Anxiety, 29(9), 749–753. https://doi.org/10.1002/da.21992.CrossRefPubMed

Derryberry, D., & Reed, M. A. (2002). Anxiety-related attentional biases and their regulation by attentional control. Journal of Abnormal Psychology, 111(2), 225–236.CrossRefPubMed

El-Mallakh, R. S., & Hollifield, M. (2008). Comorbid anxiety in bipolar disorder alters treatment and prognosis. Psychiatric Quarterly, 79(2), 139–150. https://doi.org/10.1007/s11126-008-9071-5.CrossRefPubMed

Ellard, K. K., Bernstein, E. E., Hearing, C., Baek, J. H., Sylvia, L. G., Nierenberg, A. A., et al. (2017). Transdiagnostic treatment of bipolar disorder and comorbid anxiety using the unified protocol for emotional disorders: A pilot feasibility and acceptability trial. Journal of Affective Disorders, 219, 209–221. https://doi.org/10.1016/j.jad.2017.05.011.CrossRefPubMedPubMedCentral

Eser, H. Y., Kacar, A. S., Kilciksiz, C. M., Yalcinay-Inan, M., & Ongur, D. (2018). Prevalence and associated features of anxiety disorder comorbidity in bipolar disorder: A meta-analysis and meta-regression study. Front Psychiatry, 9, 229. https://doi.org/10.3389/fpsyt.2018.00229.CrossRef

Fan, J., McCandliss, B. D., Sommer, T., Raz, A., & Posner, M. I. (2002). Testing the efficiency and independence of attentional networks. Journal of Cognitive Neuroscience, 14(3), 340–347. https://doi.org/10.1162/089892902317361886.CrossRefPubMed

Fernie, B. A., McKenzie, A., Nikcevic, A. V., Caselli, G., & Spada, M. M. (2016). The contribution of metacognitions and attentional control to decisional procrastination. The Journal of Rational-Emotive & Cognitive-Behavior Therapy, 34(1), 1–13.CrossRef

Fountoulakis, K. N., Vieta, E., Sanchez-Moreno, J., Kaprinis, S. G., Goikolea, J. M., & Kaprinis, G. S. (2005). Treatment guidelines for bipolar disorder: A critical review. Journal of Affective Disorders, 86(1), 1–10. https://doi.org/10.1016/j.jad.2005.01.004.CrossRefPubMed

Freeman, M. P., Freeman, S. A., & McElroy, S. L. (2002). The comorbidity of bipolar and anxiety disorders: Prevalence, psychobiology, and treatment issues. Journal of Affective Disorders, 68(1), 1–23.CrossRefPubMed

Goes, F. S., McCusker, M. G., Bienvenu, O. J., MacKinnon, D. F., Mondimore, F. M., Schweizer, B., et al. (2012). Co-morbid anxiety disorders in bipolar disorder and major depression: Familial aggregation and clinical characteristics of co-morbid panic disorder, social phobia, specific phobia and obsessive-compulsive disorder. Psychological Medicine, 42(7), 1449–1459. https://doi.org/10.1017/S0033291711002637.CrossRefPubMed

Goodwin, G., Haddad, P., Ferrier, I., Aronson, J., Barnes, T., Cipriani, A., et al. (2016). Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology, 30(6), 495–553. https://doi.org/10.1177/0269881116636545.CrossRefPubMed

Grafton, B., & MacLeod, C. (2014). Enhanced probing of attentional bias: The independence of anxiety-linked selectivity in attentional engagement with and disengagement from negative information. Cognition and Emotion, 28(7), 1287–1302. https://doi.org/10.1080/02699931.2014.881326.CrossRefPubMed

Grafton, B., & MacLeod, C. (2016). Engaging with the wrong people: The basis of selective attention to negative faces in social anxiety. Cognition and Emotion, 4(5), 793–804. https://doi.org/10.1177/2167702615616344.CrossRef

Groves, S. J., Porter, R. J., Jordan, J., Knight, R., Carter, J. D., McIntosh, V. V. W., et al. (2015). Changes in neuropsychological function after treatment with metacognitive therapy or cognitive behavior therapy for depression [Article]. Depress Anxiety, 32(6), 437–444. https://doi.org/10.1002/da.22341.CrossRefPubMed

Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56–62. https://doi.org/10.1136/jnnp.23.1.56.CrossRefPubMedPubMedCentral

Irak, M., & Tosun, A. (2008). Exploring the role of metacognition in obsessive–compulsive and anxiety symptoms. Journal of Anxiety Disorders, 22(8), 1316–1325. https://doi.org/10.1016/j.janxdis.2008.01.012.CrossRefPubMed

Jensen, J. H., Stottrup, M. M., Nayberg, E., Knorr, U., Ullum, H., Purdon, S. E., et al. (2015). Optimising screening for cognitive dysfunction in bipolar disorder: Validation and evaluation of objective and subjective tools. Journal of Affective Disorders, 187, 10–19. https://doi.org/10.1016/j.jad.2015.07.039.CrossRefPubMed

Johnson, S. U., Hoffart, A., Nordahl, H. M., & Wampold, B. E. (2017). Metacognitive therapy versus disorder-specific CBT for comorbid anxiety disorders: A randomized controlled trial. Journal of Anxiety Disorders, 50, 103–112. https://doi.org/10.1016/j.janxdis.2017.06.004.CrossRefPubMed

Jones, S., Knowles, D., Tyler, E., Holland, F., Peters, S., Lobban, F., et al. (2018). The feasibility and acceptability of a novel anxiety in bipolar disorder intervention compared to treatment as usual: A randomized controlled trial. Depress Anxiety, 35(10), 953–965. https://doi.org/10.1002/da.22781.CrossRefPubMed

Kauer-Sant'Anna, M., Frey, B. N., Andreazza, A. C., Ceresér, K. M., Gazalle, F. K., Tramontina, J., et al. (2007). Anxiety comorbidity and quality of life in bipolar disorder patients. The Canadian Journal of Psychiatry, 52(3), 175–181. https://doi.org/10.1177/070674370705200309.CrossRefPubMed

Kessler, R. C., Avenevoli, S., Costello, J., Green, J. G., Gruber, M. J., McLaughlin, K. A., et al. (2012). Severity of 12-month DSM-iv disorders in the national comorbidity survey replication adolescent supplement. Archives of General Psychiatry, 69(4), 381–389. https://doi.org/10.1001/archgenpsychiatry.2011.1603.CrossRefPubMedPubMedCentral

Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Archives of General Psychiatry, 62(6), 593–602. https://doi.org/10.1001/archpsyc.62.6.593.CrossRefPubMed

Kjaerstad, H. L., Mistarz, N., Coello, K., Stanislaus, S., Melbye, S. A., Harmer, C. J., et al. (2019). Aberrant cognition in newly diagnosed patients with bipolar disorder and their unaffected relatives. Psychological Medicine. https://doi.org/10.1017/s0033291719001867.CrossRefPubMed

Konnopka, A., & Konig, H. (2020). Economic burden of anxiety disorders: A systematic review and meta-analysis. Pharmacoeconomics, 38(1), 25–37. https://doi.org/10.1007/s40273-019-00849-7.CrossRefPubMed

Kraft, B., Jonassen, R., Stiles, T. C., & Landro, N. I. (2017). Dysfunctional metacognitive beliefs are associated with decreased executive control. Frontier in Psychology, 8, 593. https://doi.org/10.3389/fpsyg.2017.00593.CrossRef

Lang, P. J., Bradlet, M. M., & Cuthbert, B. N. (1997). International Affective Picture System (IAPS): Technical Manual and Affective Ratings. NIMH Center for the Study of Emotion and Attention.

Lee, J. H., & Dunner, D. L. (2008). The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders. Depress Anxiety, 25(2), 91–97. https://doi.org/10.1002/da.20279.CrossRefPubMed

Lyubomirsky, S., Layous, K., Chancellor, J., & Nelson, S. K. (2015). Thinking about rumination: The scholarly contributions and intellectual legacy of Susan Nolen-Hoeksema. Annual Review Clinical Psychology, 11, 1–22. https://doi.org/10.1146/annurev-clinpsy-032814-112733.CrossRef

Macqueen, G. M., Marriott, M., Begin, H., Robb, J., Joffe, R. T., & Young, L. T. (2003). Subsyndromal symptoms assessed in longitudinal, prospective follow-up of a cohort of patients with bipolar disorder. Bipolar Disorders, 5(5), 349–355. https://doi.org/10.1034/j.1399-5618.2003.00048.x.CrossRefPubMed

Matthews, G., & Wells, A. (2008). Rumination, depression, and metacognition: The S-REF model. 125–151.

Meyer, T. J., Miller, M. L., Metzger, R. L., & Borkovec, T. D. (1990). Development and validation of the Penn state worry questionnaire. Behaviour Research and Therapy, 28(6), 487–495.CrossRefPubMed

Miskowiak, K. W., Ott, C. V., Petersen, J. Z., & Kessing, L. V. (2016). Systematic review of randomized controlled trials of candidate treatments for cognitive impairment in depression and methodological challenges in the field. European Neuropsychopharmacology, 26(12), 1845–1867. https://doi.org/10.1016/j.euroneuro.2016.09.641.CrossRefPubMed

Montgomery, D. B. (2001). ECNP consensus meeting march 2000 nice: Guidelines for investigating efficacy in bipolar disorder. European Neuropsychopharmacology, 11(1), 79–88. https://doi.org/10.1016/S0924-977X(00)00140-1.CrossRefPubMed

Newby, J. M., McKinnon, A., Kuyken, W., Gilbody, S., & Dalgleish, T. (2015). Systematic review and meta-analysis of transdiagnostic psychological treatments for anxiety and depressive disorders in adulthood. Clinical Psychology Review, 40, 91–110. https://doi.org/10.1016/j.cpr.2015.06.002.CrossRefPubMed

Nolen-Hoeksema, S., Wisco, B. E., & Lyubomirsky, S. (2008). Rethinking. Rumination., 3(5), 400–424. https://doi.org/10.1111/j.1745-6924.2008.00088.x.CrossRef

Nordahl, H. (2009). Effectiveness of brief metacognitive therapy versus cognitive-behavioral therapy in a general outpatient setting. International Journal of Cognitive Therapy, 2, 152–159. https://doi.org/10.1521/ijct.2009.2.2.152.CrossRef

Nordahl, H., Odegaard, I. H., Hjemdal, O., & Wells, A. (2019). A test of the goodness of fit of the generic metacognitive model of psychopathology symptoms. BMC Psychiatry, 19(1), 288. https://doi.org/10.1186/s12888-019-2266-5.CrossRefPubMedPubMedCentral

Normann, N., & Morina, N. (2018). The efficacy of metacognitive therapy: A systematic review and meta-analysis. Frontier in Psychology, 9, 2211. https://doi.org/10.3389/fpsyg.2018.02211.CrossRef

O'Carroll, P. J., & Fisher, P. (2013). Metacognitions, worry and attentional control in predicting OSCE performance test anxiety. Medical Education, 47(6), 562–568. https://doi.org/10.1111/medu.12125.CrossRefPubMed

Oestefjells, T., Melle, I., Aminoff, S. R., Hellvin, T., Hagen, R., Lagerberg, T. V., et al. (2017). An exploration of metacognitive beliefs and thought control strategies in bipolar disorder. Comprehensive Psychiatry, 73, 84–92. https://doi.org/10.1016/j.comppsych.2016.11.008.CrossRef

Ott, C., Mine, H., Petersen, J. Z., & Miskowiak, K. (2019). Relation between functional and cognitive impairments in remitted patients with bipolar disorder and suggestions for trials targeting cognition: An exploratory study. Journal of Affective Disorders, 257, 382–389. https://doi.org/10.1016/j.jad.2019.07.030.CrossRefPubMed

Ott, C. A. (2018). Treatment of anxiety disorders in patients with comorbid bipolar disorder. Mental Health Clinic, 8(6), 256–263. https://doi.org/10.9740/mhc.2018.11.256.CrossRef

Pacchiarotti, I., Bond, D. J., Baldessarini, R. J., Nolen, W. A., Grunze, H., Licht, R. W., et al. (2013). The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. American Journal of Psychiatry, 170(11), 1249–1262. https://doi.org/10.1176/appi.ajp.2013.13020185.CrossRefPubMed

Papageorgiou, C. & Wells, A. (2003). An empirical test of a clinical metacognitive model of rumination and depression [journal article]. Cognitive Therapy and Research, 27(3), 261–273. https://doi.org/10.1023/a:1023962332399.CrossRef

Pavlova, B., Perlis, R. H., Mantere, O., Sellgren, C. M., Isometsa, E., Mitchell, P. B., et al. (2017). Prevalence of current anxiety disorders in people with bipolar disorder during euthymia: A meta-analysis. Psychological Medicine, 47(6), 1107–1115. https://doi.org/10.1017/s0033291716003135.CrossRefPubMed

Perlis, R. H., Ostacher, M. J., Patel, J. K., Marangell, L. B., Zhang, H., Wisniewski, S. R., et al. (2006). Predictors of recurrence in bipolar disorder: primary outcomes from the systematic treatment enhancement program for bipolar disorder (STEP-BD). American Journal of Psychiatry, 163(2), 217–224. https://doi.org/10.1176/appi.ajp.163.2.217.CrossRefPubMed

Pino, O., Guilera, G., Gomez, J., Rojo, J. E., Vellejo, J., & Purdon, S. E. (2006). A brief scale to assess cognitive impairment in psychiatric patients. Psicothema, 18(3), 447–452.PubMed

Provencher, M. D., Hawke, L. D., & Thienot, E. (2011). Psychotherapies for comorbid anxiety in bipolar spectrum disorders. Journal of Affective Disorders, 133(3), 371–380. https://doi.org/10.1016/j.jad.2010.10.040.CrossRefPubMed

Rakofsky, J. J., & Dunlop, B. W. (2011). Treating nonspecific anxiety and anxiety disorders in patients with bipolar disorder: A review. Journal of Clinical Psychiatry, 72(1), 81–90. https://doi.org/10.4088/JCP.09r05815gre.CrossRefPubMed

Sarisoy, G., Pazvantoglu, O., Ozturan, D. D., Ay, N. D., Yilman, T., Mor, S., et al. (2014). Metacognitive beliefs in unipolar and bipolar depression: A comparative study. Nordic Journal of Psychiatry, 68(4), 275–281. https://doi.org/10.3109/08039488.2013.814710.CrossRefPubMed

Schaffer, A., Isometsa, E. T., Tondo, L. D. H. M., Turecki, G., Reis, C., Cassidy, F., et al. (2015). International Society for Bipolar Disorders Task Force on Suicide: meta-analyses and meta-regression of correlates of suicide attempts and suicide deaths in bipolar disorder. Bipolar Disorder, 17(1), 1–16. https://doi.org/10.1111/bdi.12271.CrossRef

Seeberg, I., Nielsen, I. B., Jørgensen, C. K., Eskestad, N. D., & Miskowiak, K. (2020). Effects of psychological and pharmacological interventions on anxiety symptoms in patients with bipolar disorder in full or partial remission: A systematic review. Accepted upon minor revision in Journal of Affective Disorders.

Sellers, R., Emsley, R., Wells, A., & Morrison, A. P. (2018). The role of cognitive and metacognitive factors in non-clinical paranoia and negative affect. Psychology Psychotherapy, 91(2), 169–185. https://doi.org/10.1111/papt.12154.CrossRefPubMed

Sellers, R., Gaweda, L., Wells, A., & Morrison, A. P. (2016). The role of unhelpful metacognitive beliefs in psychosis: Relationships with positive symptoms and negative affect. Psychiatry Research, 246, 401–406. https://doi.org/10.1016/j.psychres.2016.10.029.CrossRefPubMed

Shah, S., Kim, J. P., Park, D. Y., Kim, H., Yuen, L. D., Do, D., et al. (2017). Lifetime anxiety disorder and current anxiety symptoms associated with hastened depressive recurrence in bipolar disorder. Journal of Affect Disorder, 219, 165–171. https://doi.org/10.1016/j.jad.2017.05.007.CrossRef

Simon, N. M., Otto, M. W., Wisniewski, S. R., Fossey, M., Sagduyu, K., Frank, E., et al. (2004). Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). American Journal of Psychiatry, 161(12), 2222–2229. https://doi.org/10.1176/appi.ajp.161.12.2222.CrossRefPubMed

Spada, M. M., Georgiou, G. A., & Wells, A. (2010). The relationship among metacognitions, attentional control, and state anxiety. Cognitive Behave Therapy, 39(1), 64–71. https://doi.org/10.1080/16506070902991791.CrossRef

Spada, M. M., & Roarty, A. (2015). The relative contribution of metacognitions and attentional control to the severity of gambling in problem gamblers. Addict Behavior Report, 1, 7–11. https://doi.org/10.1016/j.abrep.2015.02.001.CrossRef

Sun, X., Zhu, C., & So, S. H. W. (2017). Dysfunctional metacognition across psychopathologies: A meta-analytic review. Europe Psychiatry, 45, 139–153. https://doi.org/10.1016/j.eurpsy.2017.05.029.CrossRef

Tamam, L., & Ozpoyraz, N. (2002). Comorbidity of anxiety disorder among patients with bipolar I disorder in remission. Psychopathology, 35(4), 203–209. https://doi.org/10.1159/000063824.CrossRefPubMed

Wells, A. (2009). Metacognitive therapy for anxiety and depression. New York: Guilford Press.

Wells, A., & Cartwright-Hatton, S. (2004). A short form of the metacognitions questionnaire: Properties of the MCQ-30. Behaviour Research and Therapy, 42(4), 385–396. https://doi.org/10.1016/s0005-7967(03)00147-5.CrossRefPubMed

Wells, A., Fisher, P., Myers, S., Wheatley, J., Patel, T., & Brewin, C. R. (2009). Metacognitive therapy in recurrent and persistent depression: A multiple-baseline study of a new treatment. Cognitive Therapy Research, 33(3), 291–300.CrossRef

Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978). A rating scale for mania: reliability, validity and sensitivity. British Journal of Psychiatry, 133(5), 429–435.CrossRef

Zutshi, A., Reddy, Y. C., Thennarasu, K., & Chandrashekhar, C. R. (2006). Comorbidity of anxiety disorders in patients with remitted bipolar disorder. European Archives of Psychiatry and Clinical Neuroscience, 256(7), 428–436. https://doi.org/10.1007/s00406-006-0658-2.CrossRefPubMed

Titel: Residual Anxiety in Patients with Bipolar Disorder in Full or Partial Remission: Metacognitive Beliefs and Neurocognitive Function
Auteurs: M. L. Reinholdt-Dunne
I. Seeberg
A. Blicher
N. Normann
M. Vinberg
L. V. Kessing
K. W. Miskowiak
Publicatiedatum: 15-09-2020
Uitgeverij: Springer US
Gepubliceerd in: Cognitive Therapy and Research / Uitgave 1/2021
Print ISSN: 0147-5916
Elektronisch ISSN: 1573-2819
DOI: https://doi.org/10.1007/s10608-020-10148-7

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Background

Methods

Results

Conclusions

Log in om toegang te krijgen

Andere artikelen Uitgave 1/2021

Emotion-in-Motion: An ABM Approach that Modifies Attentional Disengagement from, Rather than Attentional Engagement with, Negative Information

Psychotherapy, Atomoxetine or Both? Preliminary Evidence from a Comparative Study of Three Types of Treatment for Attention-Deficit/Hyperactivity Disorder in Children

Cognitive Predictors of Depressive Symptoms: Cognitive Reactivity, Mood Reactivity, and Dysfunctional Attitudes

Manipulating Alcohol Expectancies in Social Anxiety: A Focus on Beliefs About Losing Control

Change in Attentional Control Predicts Change in Attentional Bias to Negative Information in Response to Elevated State Anxiety

Does Self-Efficacy Predict Functioning in Older Adults with Schizophrenia? A Cross-Sectional and Longitudinal Mediation Analysis